Fennec Pharmaceuticals Inc.

NASDAQ:FENC

Biotechnology

Healthcare
$13.33 -1.34%

-$0.12 today

Market cap
$470.62M
Beta
1.08
P/E (TTM)
-36.3
EPS (TTM)
-$0.24
52W Low $5.65High $10.45

Volume 0.59M

Average 0.26M

Balance Sheet

Inspect the capital base behind the business.

Assets

$70.07M

FY 2025 · Annual

+55.9% YoY

Liabilities

$35.02M

FY 2025 · Annual

-31.1% YoY

Equity

$35.05M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents21.1M23.77M13.27M26.63M36.72M
Short-term Investments00000
Net Receivables01.55M8.81M12.88M23.18M
Inventory0576K2.16M1.06M1.56M
Other Current Assets253K63K44K466K1.37M
Total Current Assets22.39M26.73M26.86M44.12M66.56M
Property, Plant & Equipment (Net)00000
Goodwill00000
Intangible Assets00000
Long-term Investments00002.79M
Tax Assets00000
Other Non-current Assets27K211K6K822K710.62K
Total Non-current Assets27K211K6K822K3.5M
Total Assets22.41M26.94M26.86M44.95M70.07M
Account Payables777K2.39M3.78M3.24M4.63M
Short-term Debt00000
Tax Payables00000
Deferred Revenue0000247.55K
Other Current Liabilities000248K(10.25K)
Total Current Liabilities1.65M4.61M7.55M6.92M10.5M
Long-term Debt4.99M24.9M30.93M19.34M0
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)000024.56M
Other Non-current Liabilities00024.56M0
Total Non-current Liabilities4.99M24.9M30.93M43.9M24.52M
Total Liabilities6.64M29.51M38.49M50.82M35.02M
Common Stock140.8M142.59M144.31M145.61M189.56M
Retained Earnings(179.49M)(203.2M)(219.25M)(219.68M)(229.36M)
Accumulated OCI1.24M1.24M1.24M1.24M1.24M
Other Stockholders Equity025.75K010
Minority Interest00000
Total Equity15.77M(2.57M)(11.62M)(5.87M)35.05M
Total Debt4.99M24.9M30.95M19.34M0
Net Debt(16.11M)1.13M17.69M(7.29M)(36.72M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$40.2M
Receivables$18.8M
Inventory$1.9M
Other Current$6.1M
Total Current Assets$66.9M
Long-term Investments$4.3M
Other Non-current$691.0K
Total Non-current Assets$4.9M
Total Assets$71.8M

Analysis

Selected assets total $71.8M for Latest. The largest visible component is Cash & Equivalents at $40.2M, about 55.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
4Statement of changes in beneficial ownershipNov 2, 2026

How much cash does FENC have?

Fennec Pharmaceuticals Inc. (FENC) reported $36.72M in cash and equivalents in fiscal 2025.

How much debt does FENC carry?

Fennec Pharmaceuticals Inc. (FENC) reported $0.00 of total debt, with net debt of -$36.72M.